151 related articles for article (PubMed ID: 7246790)
21. [Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum].
Lu WJ; Zhou J; Ma HY; Lü GH; You FQ; Ding AW; Duan JA
Yao Xue Xue Bao; 2011 Oct; 46(10):1187-92. PubMed ID: 22242448
[TBL] [Abstract][Full Text] [Related]
22. Antiarrhythmic properties of acetaminophen in the dog.
Merrill GF; Merrill JH; Golfetti R; Jaques KM; Hadzimichalis NS; Baliga SS; Rork TH
Exp Biol Med (Maywood); 2007 Oct; 232(9):1245-52. PubMed ID: 17895533
[TBL] [Abstract][Full Text] [Related]
23. Absence of cardioversion-induced ventricular arrhythmias in patients with therapeutic digoxin levels.
Mann DL; Maisel AS; Atwood JE; Engler RL; LeWinter MM
J Am Coll Cardiol; 1985 Apr; 5(4):882-90. PubMed ID: 3973290
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride.
Lynch J; Montgomery D; Ventura A; Wilber D; Lucchesi BR
Arzneimittelforschung; 1986 Mar; 36(3):475-81. PubMed ID: 3707667
[TBL] [Abstract][Full Text] [Related]
25. Correlation of antiarrhythmic effects of diphenylhydantoin with digoxin-induced changes in myocardial contractility, sodium-potassium adenosine triphosphatase activity, and potassium efflux.
Goldstein RE; Penzotti SC; Kuehl KS; Prindle KH; Hall CA; Titus EO; Epstein SE
Circ Res; 1973 Aug; 33(2):175-82. PubMed ID: 4269514
[No Abstract] [Full Text] [Related]
26. Effects of inotropic and arrhythmogenic digoxin doses and of digoxin-specific antibody on myocardial monovalent cation transport in the dog.
Hougen TJ; Lloyd BL; Smith TW
Circ Res; 1979 Jan; 44(1):23-31. PubMed ID: 758230
[TBL] [Abstract][Full Text] [Related]
27. Digoxin-induced ventricular arrhythmias in the guinea pig heart in vivo: evidence for a role of endogenous catecholamines in the genesis of delayed afterdepolarizations and triggered activity.
Xu J; Hurt CM; Pelleg A
Heart Vessels; 1995; 10(3):119-27. PubMed ID: 7673081
[TBL] [Abstract][Full Text] [Related]
28. Neuroexcitatory effects of digoxin in the cat.
Pace DG; Gillis RA
J Pharmacol Exp Ther; 1976 Dec; 199(3):583-600. PubMed ID: 994017
[TBL] [Abstract][Full Text] [Related]
29. Influence of pretreatment with phenytoin, lidocaine and quinidine on the cardiodynamic and electrophysiological effects of ouabain in the cat heart-lung preparation.
Simaan JA
Arch Int Pharmacodyn Ther; 1993; 324():47-59. PubMed ID: 8297185
[TBL] [Abstract][Full Text] [Related]
30. The interrelationship of morphine and the parasympathetic nervous system in digoxin-induced arrhythmias in the guinea-pig.
Rabkin SW
Clin Exp Pharmacol Physiol; 1988 Aug; 15(8):565-73. PubMed ID: 3271626
[TBL] [Abstract][Full Text] [Related]
31. Cardiotoxic interaction of metabolites from a prodrug segment cilexetil (cyclohexyloxy-carbonyloxy-ethyl) with digoxin in the canine failing heart.
Okunishi H; Shimoura K; Wang DQ; Kakizoe E
Pharmacol Res; 2002 Oct; 46(4):301-10. PubMed ID: 12361690
[TBL] [Abstract][Full Text] [Related]
32. Digoxin toxicity compared with myocardial digoxin and potassium concentration.
Steiness E
Br J Pharmacol; 1978 Jun; 63(2):233-7. PubMed ID: 667416
[TBL] [Abstract][Full Text] [Related]
33. Ketanserin inhibits digoxin-induced arrhythmias in the anaesthetized guinea-pig.
Kalyoncu NI; Ozyavuz R
Fundam Clin Pharmacol; 1999; 13(6):646-9. PubMed ID: 10626751
[TBL] [Abstract][Full Text] [Related]
34. Atropine-induced ventricular ectopic arrhythmias and fibrillation.
Page CP; Deaton WJ; Warren BH; Hoff GE
Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):469-77. PubMed ID: 5968524
[No Abstract] [Full Text] [Related]
35. The effect of acetyl strophanthidin on the hearts of normal dogs.
Hayes AH; McShane WP; Sidell FR
Br J Pharmacol; 1970 May; 38(3):616-9. PubMed ID: 5441414
[TBL] [Abstract][Full Text] [Related]
36. Studies on the possible mechanisms of lidoflazine arrhythmogenicity.
Keren G; Tepper D; Butler B; Maguire W; Willens H; Miura D; Somberg JC
J Am Coll Cardiol; 1984 Oct; 4(4):742-7. PubMed ID: 6481014
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of poly (ADP-ribose) synthase inhibitors on digoxin-induced cardiotoxicity in guinea-pig isolated hearts.
Demiryürek AT; Yildiz G; Eşiyok S; Altuğ S
Pharmacol Res; 2002 Mar; 45(3):189-94. PubMed ID: 11884214
[TBL] [Abstract][Full Text] [Related]
38. Digoxin enhances bupivacaine toxicity in rats.
De Kock M; Gautier P; Vandewalle F; Renotte MT
Reg Anesth; 1991; 16(5):272-7. PubMed ID: 1958605
[TBL] [Abstract][Full Text] [Related]
39. Potassium canrenoate in the treatment of long-term digoxin-induced arrhythmias in conscious dogs.
deGuzman NT; Yeh BK
Am J Cardiol; 1975 Mar; 35(3):413-20. PubMed ID: 1114999
[TBL] [Abstract][Full Text] [Related]
40. Effects of platelet-activating factor antagonists WEB 2086 and BN 50730 on digoxin-induced arrhythmias.
Cakici I; Mataraci N; Ersoy S; Tunçtan B; Abacioğlu N; Kanzik I
Pharmacol Toxicol; 1995 Jun; 76(6):343-7. PubMed ID: 7479573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]